• Теги
    • избранные теги
    • Компании2672
      • Показать ещё
      Разное597
      • Показать ещё
      Международные организации58
      • Показать ещё
      Страны / Регионы470
      • Показать ещё
      Люди70
      • Показать ещё
      Формат16
      Показатели34
      • Показать ещё
      Издания25
      • Показать ещё
      Сферы3
23 июня, 16:38

Regeneron (REGN) Stock on Fire: What's Behind the Surge?

Shares of Regeneron Pharmaceuticals, Inc. (REGN) have moved up 14.8% over the last 30 days.

Выбор редакции
23 июня, 14:42

Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod

All major pharma stocks were up this week with companies like Novartis (NVS) presenting positive data and others gaining FDA approval.

Выбор редакции
22 июня, 20:14

Novartis' CANTOS Heart Trial Results Could Lead To Drastic Drop In Arthritis Drug Price

But who would have thought at the results of a heart disease study could potentially provide an unexpected financial benefit to those patients with juvenile arthritis.

Выбор редакции
22 июня, 16:47

Novartis Announces Positive Results for Cardiovascular Drug

Novartis AG (NVS) announced top-line results from the global phase III study, CANTOS on cardiovascular drug.

Выбор редакции
22 июня, 15:21

Novartis Drug Becomes First To Prevent Heart Attacks And Strokes By Targeting Inflammation

This morning, Novartis, the Swiss drug giant, announced that a drug that targets inflammation prevented heart attacks and strokes. It could be a scientific breakthrough, and a commercial one, too.

Выбор редакции
22 июня, 00:40

Ligand Gets Milestone Payment on Partner Drug FDA Approval

Ligand Pharmaceuticals Incorporated (LGND) announced receipt of a milestone payment of $1.5 million after its partner Melinta Therapeutics' pipeline candidate Baxdela (delafloxacin) was approved by the FDA.

21 июня, 18:16

Novartis Migraine Drug Accepted, AMD Positive in Phase III

Novartis (NVS) announced that the EMA accepted its application for migraine candidate AMG 334.

20 июня, 21:55

Gilead's (GILD) HBV Drug Vemlidy Receives Approval in Canada

Health Canada granted a Notice of Compliance (NOC) for Vemlidy 25mg tablets, a once-daily treatment for adults with chronic HBV infection with compensated liver disease.

Выбор редакции
20 июня, 18:46

Regeneron stock surges 6% after Novartis releases positive data for rival drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Выбор редакции
20 июня, 18:18

Amgen's Xgeva Myeloma Label Expansion sBLA Accepted by FDA

Amgen Inc. (AMGN) announced that the FDA has accepted its supplemental Biologics License Application (sBLA) to expand the label of its key drug, Xgeva.

Выбор редакции
19 июня, 23:56

Novartis (NVS) Biosimilar of MabThera Approved in the EU

Novartis AG (NVS) announced that its generic arm, Sandoz, has received European Commission (EC) approval for Rixathon.

Выбор редакции
19 июня, 15:53

3 Biotech Stocks That More than Doubled Year to Date

Here is a look at Puma (PBYI) and two other biotech stocks that have recorded massive gains so far in 2017.

16 июня, 15:27

Pharma Stock Roundup: J&J, Lilly Present Data, Merck Keytruda Study Enrolment Paused

Merck (MRK) paused patient enrolment in a couple of studies being conducted with its anti-PD-1 therapy, Keytruda.

16 июня, 11:39

Фондовые рынки Европы растут в пятницу

Фондовые индексы стран Западной Европы повышаются в пятницу на сильных статданных о продажах автомобилей в ЕС в мае.